Safety and Tolerability of Cariprazine in the Long-Term Treatment of Schizophrenia: Results From a 48-Week Extension Study. VIEW POSTER

An Extended-Release Formulation of Clonidine Hydrochloride Tablets for the Treatment of ADHD in Children and Adolescents with Inadequate Response to Stimulants. Patti Treubert, BS, LPN;1 Andrew J. Cutler, MD;1 Rafael Muniz, MD2. (Presented at the 25th Annual American Psychiatric Nurse Association October 19-22, 2011, Anaheim, CA). VIEW POSTER

Efficacy and Tolerability of Vilazodone, a Dual-Acting Serotonergic Antidepressant, in the Treatment of Patients With Major Depressive Disorder (MDD). (Presented at the American Psychiatric Association’s 62nd Institute on Psychiatric Services, October 14-17, 2010, Boston, Massachusetts.) VIEW POSTER.

Extended-Release Dexmethylphenidate 30 mg is Safe, Well Tolerated and Improves Duration of Action in Children With ADHD. (Poster presented at the US Psychiatric and Mental Health Congress, November 18–21, 2010, Orlando, FL, USA.) VIEW POSTER.

LONG-TERM SAFETY AND EFFICACY OF ILOPERIDONE: RESULTS FROM AN OPEN-LABEL, 25-215 WEEK CLINICAL TRIAL. VIEW POSTER.

Double-Blind, Placebo-Controlled Efficacy and Safety Study of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder. (Presented at the 49th Annual Meeting of American College of Neuropsychopharmacology. December 5-9, 2010; Miami Beach, FL.) VIEW POSTER.

Double-Blind, Placebo-Controlled Efficacy and Safety Study of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder. 2010. VIEW POSTER.

A Multicenter Placebo-Controlled Study of Extended-Release Guanfacine Coadministered With Psychostimulants in the Treatment of Attention-Deficit/Hyperactivity Disorder: Effects on Overall, Morning, and Evening ADHD Assessments. 2010. VIEW POSTER.

Extended release quetiapine fumarate (quetiapine XR) monotherapy for generalized anxiety disorder (GAD): a randomised, placebo- and escitalopram-controlled study. 2009. VIEW POSTER.

Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar mania. Version 1.  2008. VIEW POSTER.

Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar mania. Version 2.  2008. VIEW POSTER.

Efficacy and tolerability of extended release quetipine fumarate (quetiapine XR) monotherapy in the treatment of generalized anxiety disorder (GAD). 2008. VIEW POSTER.

The Metabolic Profile Of Iloperidone: Summary Of Phase 3 Schizophrenia Trials. 2008. VIEW POSTER.

Extended release quetiapine fumarate (quetiapine XR) monotherapy in the treatment of patients with major depressive disorder (MDD). 2008. VIEW POSTER.

Extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder (MDD): results from a double-blind, randomized Phase III study. 2007. VIEW POSTER.

Long-Term Efficacy, Safety, and Tolerability of Mixed Amphetamine Salts Extended Release in the Treatment of Adolescents With ADHD. 2007. VIEW POSTER.

Predictors Of Response To Treatment Of Bipolar Disorder With Extended-Release Carbamazepine Capsules In 2 Double-Blind, Randomized, Placebo-Controlled Trials. 2005. VIEW POSTER.

Efficacy Of Switching To Carbamazepine Extended-Release Capsules In Bipolar Disorder. 2005. VIEW POSTER.

Symptomatic Remission of ADHD in Children and Adolescents With Coadministration of Guanfacine Extended Release and a Psychostimulant. VIEW POSTER.